HAL (France)open access
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study
Mepolizumab, 0, Patient-reported outcomes, Eosinophilic granulomatosis with polyangiitis, Health-related quality of life, ANCA-associated vasculitis patient-reported outcomes questionnaire
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1120226
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.